Nephros: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Nephros (NASDAQ:NEPH) reported its Q3 earnings, beating estimated earnings by 66.67% with an EPS of $-0.02 versus an estimate of $-0.06. Revenue was up $1.33 million from the same period last year. Last quarter, the company beat on EPS by $0.01, which was followed by a 7.86% increase in the share price the next day.
November 08, 2023 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nephros reported better than expected Q3 earnings, which could lead to a positive impact on its stock price, as seen in the previous quarter.
Nephros has reported better than expected earnings for Q3, beating estimates by 66.67%. This is a positive signal for investors and could lead to an increase in the stock price. The company's past performance shows a pattern of beating estimates and subsequent increases in stock price, which further supports this prediction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100